AGP Executive Report
Last update: 3 hours agoAging Milestone: Japan’s centenarians have topped 100,000 for the first time, reaching 107,677 people aged 100+ (about 88% women), underscoring how medical advances are keeping older adults active. Care Innovation: A virtual zoo program is letting children in Japanese hospitals explore places like Osaka’s Tennoji Zoo via VR, aiming to ease isolation during long cancer and serious illness stays. Nutrition & Brain Health: A decade-long Japanese study links higher mushroom intake with better short-term and working memory scores in middle-aged and older adults, while stressing it shows correlation, not cause. End-of-Life System Pressure: Japan’s “unclaimed bodies” trade is expanding, with some private firms storing remains in warehouses and charging municipalities low fees—raising concerns about oversight and transparency. Rare Disease Treatment: Japan has approved a new treatment option for a rare genetic liver disorder, adding to the growing pipeline of targeted therapies. Menopause Drug Explained: Coverage breaks down how the menopause drug Veoza works differently from hormone therapy for hot flushes and night sweats. Pediatrics & Family Support: Ronald McDonald House Kyoto broke ground to give families a home-like base near major hospitals while children receive treatment. Health Tech Funding: RegCell secured $66 million in Japan-linked funding to move immune-tolerance cell therapy toward the clinic for autoimmune diseases. Digital Health Research: Singapore’s precision medicine push is highlighted as a way to speed clinical-trial matching and improve diagnoses.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.